Related references
Note: Only part of the references are listed.Fluorescent labeling of CRISPR/Cas9 RNP for gene knockout in HSPCs and iPSCs reveals an essential role for GADD45b in stress response
Masoud Nasri et al.
BLOOD ADVANCES (2019)
A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease
Liuhong Cai et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
Chiara Antoniani et al.
BLOOD (2018)
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
Miriam Y. Kim et al.
CELL (2018)
Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus
Alejandra Gutierrez-Guerrero et al.
HUMAN GENE THERAPY (2018)
Partial DNA-guided Cas9 enables genome editing with reduced off-target activity
Hao Yin et al.
NATURE CHEMICAL BIOLOGY (2018)
Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
Gabriella E. Martyn et al.
NATURE GENETICS (2018)
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
A. A. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Expression of inflammasome proteins and inflammasome activation occurs in human, but not in murine keratinocytes
Jennifer Sand et al.
CELL DEATH & DISEASE (2018)
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L. Roth et al.
NATURE (2018)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas et al.
NATURE MEDICINE (2018)
Editing the Genome Ex Vivo Stem Cell Therapy
Yiping Fan et al.
CURRENT STEM CELL REPORTS (2018)
CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
Xiaojuan Liu et al.
CELL RESEARCH (2017)
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
Jiangtao Ren et al.
CLINICAL CANCER RESEARCH (2017)
CRISPR/Cas9-mediated somatic and germline gene correction to restore hemostasis in hemophilia B mice
Cong Huai et al.
HUMAN GENETICS (2017)
Targeted introduction and effective expression of hFIX at the AAVS1 locus in mesenchymal stem cells
Shu-Jun Li et al.
MOLECULAR MEDICINE REPORTS (2017)
Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction
Colin L. Sweeney et al.
MOLECULAR THERAPY (2017)
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
Lei Xu et al.
MOLECULAR THERAPY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
Florian Eichler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease
Suk See De Ravin et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1
Giulia Schiroli et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice
Tsukasa Ohmori et al.
SCIENTIFIC REPORTS (2017)
One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection
Yali Liu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy
Erika Zonari et al.
STEM CELL REPORTS (2017)
Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model
Jamal Alzubi et al.
SCIENTIFIC REPORTS (2017)
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned
Richard A. Morgan et al.
CELL STEM CELL (2017)
Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients
Begona Diez et al.
EMBO MOLECULAR MEDICINE (2017)
Neutrophils in cystic fibrosis
Julie Laval et al.
BIOLOGICAL CHEMISTRY (2016)
Optimizing autologous cell grafts to improve stem cell gene therapy
Nikoletta Psatha et al.
EXPERIMENTAL HEMATOLOGY (2016)
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-Globin Gene
Olivier Negre et al.
HUMAN GENE THERAPY (2016)
Cystic Fibrosis Lung Immunity: The Rose of the Macrophage
Emanuela M. Bruscia et al.
JOURNAL OF INNATE IMMUNITY (2016)
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
Mario Sessa et al.
LANCET (2016)
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Megan D. Hoban et al.
MOLECULAR THERAPY (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease
Suk See De Ravin et al.
NATURE BIOTECHNOLOGY (2016)
A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
Elizabeth A. Traxler et al.
NATURE MEDICINE (2016)
Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
Lin Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A. DeWitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Autoinflammatory Skin Disorders: The Inflammasomme in Focus
Prajwal Gurung et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients
Samuel Groeschel et al.
JAMA NEUROLOGY (2016)
CAR T Cell Therapy: A Game Changer in Cancer Treatment
Hilde Almasbak et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing
Yuichiro Miyaoka et al.
SCIENTIFIC REPORTS (2016)
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
Navneet S. Majhail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells
Anne-Kathrin Dreyer et al.
BIOMATERIALS (2015)
CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells
Rowan Flynn et al.
EXPERIMENTAL HEMATOLOGY (2015)
Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome
Salima Hacein-Bey Abina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Inhibition of HIV-1 infection of primary CD4(+) T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9
Chang Li et al.
JOURNAL OF GENERAL VIROLOGY (2015)
An AAVS1-Targeted Minigene Platform for Correction of iPSCs From All Five Types of Chronic Granulomatous Disease
Randall K. Merling et al.
MOLECULAR THERAPY (2015)
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Matthew C. Canver et al.
NATURE (2015)
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
Jianbin Wang et al.
NATURE BIOTECHNOLOGY (2015)
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
Blythe D. Sather et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting
Chia-Wei Chang et al.
CELL REPORTS (2015)
A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy
Kerstin Pohl et al.
BLOOD (2014)
Gene Therapy for Hemoglobinopathies The State of the Field and the Future
Shanmuganathan Chandrakasan et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Hematopoietic stem cells for cancer immunotherapy
Eric Gschweng et al.
IMMUNOLOGICAL REVIEWS (2014)
The Inflammasomes in Autoinflammatory Diseases with Skin Involvement
Hans-Dietmar Beer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Targeted genome editing in human repopulating haematopoietic stem cells
Pietro Genovese et al.
NATURE (2014)
CRISPR-Cas systems for editing, regulating and targeting genomes
Jeffry D. Sander et al.
NATURE BIOTECHNOLOGY (2014)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry
Loren Gragert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
S. Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Gene Therapy for Wiskott-Aldrich Syndrome-Long-Term Efficacy and Genotoxicity
Christian Joerg Braun et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Hematopoietic Stem Cell Transplantation-50 Years of Evolution and Future Perspectives
Israel Henig et al.
RAMBAM MAIMONIDES MEDICAL JOURNAL (2014)
Risk and prognostic factors for acute GVHD based on NIH consensus criteria
S-E Lee et al.
BONE MARROW TRANSPLANTATION (2013)
Advances in the treatment of acute graft-versus-host disease
Liren Qian et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases
Lijing Li et al.
MOLECULAR THERAPY (2013)
The Molecular Basis of β-Thalassemia
Swee Lay Thein
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Hematopoietic stem cell transplantation: clinical use and perspectives
Francisco Barriga et al.
BIOLOGICAL RESEARCH (2012)
Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
Karen K. Ballen et al.
BLOOD (2012)
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
Madan Jagasia et al.
BLOOD (2012)
Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders
Daniel E. Bauer et al.
BLOOD (2012)
Pathophysiology and Clinical Manifestations of the β-Thalassemias
Arthur W. Nienhuis et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Hemoglobinopathies Clinical Manifestations, Diagnosis, and Treatment
Elisabeth Kohne
DEUTSCHES ARZTEBLATT INTERNATIONAL (2011)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
Carmine Carpenito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Monocyte-mediated defense against microbial pathogens
Natalya V. Serbina et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery
Angelo Lombardo et al.
NATURE BIOTECHNOLOGY (2007)
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott et al.
NATURE MEDICINE (2006)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin
C May et al.
NATURE (2000)
Share Paper
